Evaluation of in-vitro and in-vivo antibacterial activity of tosufloxacin tosilate.
Yamaguchi
K
K
School of Medicine, Toho University, Department of Microbiology, 5-21-6 Omori-Nishi, Ota-ku, Tokyo 143-8540, Japan.e-mail: keizo@med.toho-u.ac.jp
D000818:Animals; D000890:Anti-Infective Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D002689:Chlamydia / Q000187:drug effects; D017714:Community-Acquired Infections / Q000188:drug therapy; D004195:Disease Models, Animal; D024841:Fluoroquinolones; D006090:Gram-Negative Bacteria / Q000187:drug effects*; D006094:Gram-Positive Bacteria / Q000187:drug effects*; D006801:Humans; D016952:Legionella pneumophila / Q000187:drug effects; D051379:Mice; D008826:Microbial Sensitivity Tests; D009287:Naphthyridines / Q000494:pharmacology* / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy*; D013296:Streptococcus pneumoniae / Q000187:drug effects; D013329:Structure-Activity Relationship
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C055185:tosufloxacin